Adial Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary

Adial Pharmaceuticals

21/08/2023 22:01

* Adial Pharmaceuticals Inc  ADIL.OQ  reported quarterly
adjusted
earnings of 96 cents​​ per share for the quarter ended in June.
The mean expectation of two analysts for the quarter was for a
loss of $1.50 per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Adial Pharmaceuticals Inc's reported EPS for the quarter
was 96
cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Adial Pharmaceuticals Inc shares had fallen by 34.5% this
quarter and lost 36.6% so far this year.
    * The company reported quarterly net income of $1.09
million.
    * Wall Street's median 12-month price target for Adial
Pharmaceuticals Inc is $91.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 21 at 09:01 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -1.50          0.96           Beat
 Mar. 31 2023      -3.50          -2.75          Beat
 Dec. 31 2022      -3.75          -2.75          Beat
 Sep. 30 2022      -4.50          -3.00          Beat